Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ABCL
ABCL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABCL News
Jazz Pharmaceuticals and AbCellera Sign $848M Agreement for Antibody Development
4d ago
seekingalpha
Jazz Pharmaceuticals Partners with AbCellera for Antibody Development
4d ago
PRnewswire
Jazz Pharmaceuticals Partners with AbCellera for Antibody Development
4d ago
Newsfilter
AbCellera Appoints New Independent Director
Jun 05 2026
Newsfilter
AbCellera Biologics Q1 2026 Earnings Call Insights Highlight Key Developments
May 12 2026
seekingalpha
AbCellera Biologics to Announce Q1 Earnings on May 11
May 11 2026
seekingalpha
ABCL635 Non-Hormonal Treatment Progresses Significantly
May 09 2026
stocktwits
AbCellera to Reveal Interim Results for ABCL635 in Q1 2026 Earnings Call
Apr 20 2026
Newsfilter
AbCellera to Announce Q1 2026 Financial Results
Apr 01 2026
Newsfilter
Axon Reports Q4 Revenue and Earnings Beat Estimates
Feb 25 2026
Benzinga
AbCellera Biologics Reports Earnings Beat, Shares Surge
Feb 25 2026
Benzinga
AbCellera Biologics Set to Announce FY Earnings Results
Feb 23 2026
seekingalpha
11 Stocks That Have Plummeted and Appear to Be Good Investment Opportunities
Feb 09 2026
Barron's
Salesforce Shares and 10 Other Stocks That Have Plummeted and Appear to Be Good Investments
Feb 09 2026
Barron's
AbCellera Biologics Initiates Phase 2 of pPREMIUM Clinical Trial
Jan 12 2026
Yahoo Finance
AbCellera resolves patent dispute with Bruker regarding microfluidic technology.
Dec 18 2025
SeekingAlpha
Show More News
